Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
J Clin Psychopharmacol ; 37(4): 429-434, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-28609307

RESUMEN

BACKGROUND: The aim of this study was to identify factors associated with relapse in panic disorder (PD). METHODS: This was an observational study conducted in the outpatient clinic of a psychiatric hospital in Rio de Janeiro, Brazil. In a previous study, 120 patients diagnosed as having PD according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria were randomized to receive clonazepam or paroxetine. After 3 years, treatment was discontinued in patients who had achieved remission. These subjects were included in the current study and were followed up for 6 years. The follow-up assessments were made at 1, 2, 3, 5, and 6 years after treatment discontinuation. Assessment included the number of panic attacks per month, Clinical Global Impression-Severity, and other measures. Patients who had initiated psychotherapy or pharmacological treatment because of PD symptoms or who had Clinical Global Impression-Severity scores greater than 1 or panic attacks in the month preceding the assessment were considered relapse cases. Data were collected from January 2003 to August 2012. RESULTS: Eighty-five patients completed the follow-up. Cumulative relapse rates were 50% (n = 33) at 1 year and 89.4% (n = 76) at 6 years. One-year relapse rates were lower in patients previously treated with clonazepam (P = 0.001) compared with those treated with paroxetine. Low 6-year relapse rates were associated with high Hamilton Anxiety Rating Scale scores before treatment (P = 0.016) and previous treatment with clonazepam. CONCLUSIONS: Relapse is a frequent problem in PD, and long-term treatment does not protect these patients in the long run. Treatment with clonazepam predicts lower relapse when compared with paroxetine.


Asunto(s)
Clonazepam/uso terapéutico , Trastorno de Pánico/diagnóstico , Trastorno de Pánico/tratamiento farmacológico , Paroxetina/uso terapéutico , Adulto , Femenino , Estudios de Seguimiento , Moduladores del GABA/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Estudios Prospectivos , Recurrencia , Inhibidores Selectivos de la Recaptación de Serotonina/uso terapéutico , Factores de Tiempo , Resultado del Tratamiento , Adulto Joven
2.
J Clin Psychopharmacol ; 32(1): 120-6, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22198456

RESUMEN

This long-term extension of an 8-week randomized, naturalistic study in patients with panic disorder with or without agoraphobia compared the efficacy and safety of clonazepam (n = 47) and paroxetine (n = 37) over a 3-year total treatment duration. Target doses for all patients were 2 mg/d clonazepam and 40 mg/d paroxetine (both taken at bedtime). This study reports data from the long-term period (34 months), following the initial 8-week treatment phase. Thus, total treatment duration was 36 months. Patients with a good primary outcome during acute treatment continued monotherapy with clonazepam or paroxetine, but patients with partial primary treatment success were switched to the combination therapy. At initiation of the long-term study, the mean doses of clonazepam and paroxetine were 1.9 (SD, 0.30) and 38.4 (SD, 3.74) mg/d, respectively. These doses were maintained until month 36 (clonazepam 1.9 [SD, 0.29] mg/d and paroxetine 38.2 [SD, 3.87] mg/d). Long-term treatment with clonazepam led to a small but significantly better Clinical Global Impression (CGI)-Improvement rating than treatment with paroxetine (mean difference: CGI-Severity scale -3.48 vs -3.24, respectively, P = 0.02; CGI-Improvement scale 1.06 vs 1.11, respectively, P = 0.04). Both treatments similarly reduced the number of panic attacks and severity of anxiety. Patients treated with clonazepam had significantly fewer adverse events than those treated with paroxetine (28.9% vs 70.6%, P < 0.001). The efficacy of clonazepam and paroxetine for the treatment of panic disorder was maintained over the long-term course. There was a significant advantage with clonazepam over paroxetine with respect to the frequency and nature of adverse events.


Asunto(s)
Anticonvulsivantes/administración & dosificación , Clonazepam/administración & dosificación , Trastorno de Pánico/tratamiento farmacológico , Paroxetina/administración & dosificación , Inhibidores Selectivos de la Recaptación de Serotonina/administración & dosificación , Adolescente , Adulto , Anticonvulsivantes/efectos adversos , Brasil , Clonazepam/efectos adversos , Quimioterapia Combinada , Femenino , Humanos , Entrevista Psicológica , Cuidados a Largo Plazo , Masculino , Persona de Mediana Edad , Trastorno de Pánico/diagnóstico , Trastorno de Pánico/psicología , Paroxetina/efectos adversos , Inventario de Personalidad , Estudios Prospectivos , Retratamiento , Inhibidores Selectivos de la Recaptación de Serotonina/efectos adversos , Adulto Joven
3.
Braz J Psychiatry ; 43(6): 605-612, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33787758

RESUMEN

OBJECTIVE: Decades of research have highlighted the involvement of the prefrontal cortex, anterior cingulated cortex, and limbic areas (amygdala) in panic disorder (PD). However, little attention has been given specifically to the inferior frontal gyrus. The current study aimed to investigate the neural substrates, including the inferior frontal gyrus, of both panic-related and negative conditions among individuals with PD and healthy controls. METHODS: We examined 13 medication-free PD patients and 14 healthy controls with functional magnetic resonance imaging (fMRI) during exposure to negative and neutral pictures and a set of specific panic-related pictures. RESULTS: Subtraction between the conditions indicated activation of the left amygdala region and the right inferior frontal gyrus in PD patients during the specific panic-related condition, whereas the left amygdalar region and left inferior frontal gyrus were activated during the negative condition in controls. CONCLUSION: These results suggest that in patients with PD, a prominent bottom-up process is involved in specific panic-related conditions, which might be associated with weak modulation of the left frontal area. These data add to our current understanding of the neural correlates of PD and can contribute to future clinical interventions targeting the functional reestablishment of these regions.


Asunto(s)
Trastorno de Pánico , Encéfalo/diagnóstico por imagen , Emociones , Humanos , Imagen por Resonancia Magnética , Trastorno de Pánico/diagnóstico por imagen , Corteza Prefrontal
5.
Braz J Psychiatry ; 38(4): 338-346, 2016 Aug 04.
Artículo en Inglés | MEDLINE | ID: mdl-27508396

RESUMEN

OBJECTIVE:: Major depressive disorder (MDD) is a prevalent psychiatric condition characterized by multiple symptoms that cause great distress. Uncovering the brain areas involved in MDD is essential for improving therapeutic strategies and predicting response to interventions. This systematic review discusses recent findings regarding cortical alterations in depressed patients during emotional or cognitive tasks, as measured by electroencephalography (EEG). METHODS:: A search of the MEDLINE/PubMed and Cochrane databases was carried out using the keywords EEG and depression, confined to article title. RESULTS:: The studies identified reveal the frontal cortex as an important brain structure involved in the complex neural processes associated with MDD. Findings point to disorganization of right-hemisphere activity and deficient cognitive processing in MDD. Depressed individuals tend to ruminate on negative information and respond with a pattern of relatively higher right frontal activity to emotional stimuli associated with withdrawal and isolation. CONCLUSION:: Patients with MDD may have altered dynamic patterns of activity in several neuroanatomical structures, especially in prefrontal and limbic areas involved in affective regulation. Identification of these alterations might help predict the response of patients to different interventions more effectively and thus maximize the effects both of pharmacotherapeutic and of psychotherapeutic strategies.


Asunto(s)
Encéfalo/fisiopatología , Cognición/fisiología , Trastorno Depresivo Mayor/fisiopatología , Electroencefalografía , Emociones/fisiología , Mapeo Encefálico , Corteza Cerebral/fisiopatología , Trastorno Depresivo Mayor/diagnóstico , Trastorno Depresivo Mayor/psicología , Humanos
6.
Braz. J. Psychiatry (São Paulo, 1999, Impr.) ; Braz. J. Psychiatry (São Paulo, 1999, Impr.);38(4): 338-346, Oct.-Dec. 2016. tab, graf
Artículo en Inglés | LILACS | ID: lil-798094

RESUMEN

Objective: Major depressive disorder (MDD) is a prevalent psychiatric condition characterized by multiple symptoms that cause great distress. Uncovering the brain areas involved in MDD is essential for improving therapeutic strategies and predicting response to interventions. This systematic review discusses recent findings regarding cortical alterations in depressed patients during emotional or cognitive tasks, as measured by electroencephalography (EEG). Methods: A search of the MEDLINE/PubMed and Cochrane databases was carried out using the keywords EEG and depression, confined to article title. Results: The studies identified reveal the frontal cortex as an important brain structure involved in the complex neural processes associated with MDD. Findings point to disorganization of right-hemisphere activity and deficient cognitive processing in MDD. Depressed individuals tend to ruminate on negative information and respond with a pattern of relatively higher right frontal activity to emotional stimuli associated with withdrawal and isolation. Conclusion: Patients with MDD may have altered dynamic patterns of activity in several neuroanatomical structures, especially in prefrontal and limbic areas involved in affective regulation. Identification of these alterations might help predict the response of patients to different interventions more effectively and thus maximize the effects both of pharmacotherapeutic and of psychotherapeutic strategies.


Asunto(s)
Humanos , Encéfalo/fisiopatología , Cognición/fisiología , Trastorno Depresivo Mayor/fisiopatología , Electroencefalografía , Emociones/fisiología , Mapeo Encefálico , Corteza Cerebral/fisiopatología , Trastorno Depresivo Mayor/diagnóstico , Trastorno Depresivo Mayor/psicología
7.
Psicol. reflex. crit ; 22(1): 128-135, 2009.
Artículo en Portugués | LILACS | ID: lil-517387

RESUMEN

O cérebro em desenvolvimento segue inicialmente um plano genético, estabelecido pela história evolutiva da espécie humana, porém é muito sensível ao ambiente. Estímulos ambientais modificam a estrutura dos circuitos neurais, refinando e tornando as sinapses, alvo de ação dos neurotransmissores, mais eficientes por meio de atividade elétrica e mensageiros químicos. O objetivo desse estudo é discutir teoricamente como a plasticidade e a especificação prévia de sistemas cerebrais coexistem no cérebro. Conclui-se destacando a importância de integrar aspectos de aprendizagem social e da biologia na construção e refinamento das variadas habilidades humanas.


The developing brain requires a genetic plan, established by the evolutionary history of human species, but it is also very sensitive to the surrounding environment. Environmental stimuli can modify the structure of neural circuits, refining and making synapses, which are the target of neurotransmitters, more efficient by electrical activity and chemical messengers. The aim of the present study is to discuss theoretically how both plasticity and previous specification of brain systems coexist in the brain. The conclusion shows the importance to integrate aspects of social learning and biology in building and refining the various humane skills.


Asunto(s)
Plasticidad Neuronal , Autopsicología , Neurociencias
8.
Psicol. reflex. crit ; 22(1): 128-135, 2009.
Artículo en Portugués | Index Psi (psicología) | ID: psi-44419

RESUMEN

O cérebro em desenvolvimento segue inicialmente um plano genético, estabelecido pela história evolutiva da espécie humana, porém é muito sensível ao ambiente. Estímulos ambientais modificam a estrutura dos circuitos neurais, refinando e tornando as sinapses, alvo de ação dos neurotransmissores, mais eficientes por meio de atividade elétrica e mensageiros químicos. O objetivo desse estudo é discutir teoricamente como a plasticidade e a especificação prévia de sistemas cerebrais coexistem no cérebro. Conclui-se destacando a importância de integrar aspectos de aprendizagem social e da biologia na construção e refinamento das variadas habilidades humanas.(AU)


The developing brain requires a genetic plan, established by the evolutionary history of human species, but it is also very sensitive to the surrounding environment. Environmental stimuli can modify the structure of neural circuits, refining and making synapses, which are the target of neurotransmitters, more efficient by electrical activity and chemical messengers. The aim of the present study is to discuss theoretically how both plasticity and previous specification of brain systems coexist in the brain. The conclusion shows the importance to integrate aspects of social learning and biology in building and refining the various humane skills.(AU)


Asunto(s)
Plasticidad Neuronal , Autopsicología , Neurociencias
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda